Suppr超能文献

促肾上腺皮质激素免疫测定在亚临床库欣综合征患者中的干扰

ADRENOCORTICOTROPIC HORMONE IMMUNOASSAY INTERFERENCE IN A PATIENT WITH SUBCLINICAL HYPERCORTISOLISM.

作者信息

Ozgen Saydam B, Adiyaman S C, Demir L, Yener S

机构信息

Dokuz Eylul University Hospital, Division of Endocrinology and Metabolism, Izmir, Turkey.

Izmir Katip Celebi University, Ataturk Training and Research Hospital, Department of Biochemistry, Izmir, Turkey.

出版信息

Acta Endocrinol (Buchar). 2020 Jul-Sep;16(3):379-382. doi: 10.4183/aeb.2020.379.

Abstract

CONTEXT

Immunoassays are vulnerable to occasional analytical errors despite their sensitivity and specificity. Adrenocorticotropic hormone (ACTH) is among hormones which are vulnerable to assay interference.

OBJECTIVE

In this case report, we aimed to present a case of ACTH interference in a patient with subclinical hypercortisolism.

CASE REPORT

We present a case of subclinical hypercortisolism with unexpectedly elevated levels of ACTH in whom interference was shown by different biochemical methods.It is important for the clinician to keep in mind the possibility of interference when clinical and laboratory results are discordant. The communication between the clinician and laboratory staff is important while interpreting results. This case report shows that ACTH interference should be considered in patients with subclinical hypercortisolism who have unexpectedly high levels of adrenocorticotropic hormone.

摘要

背景

免疫测定尽管具有敏感性和特异性,但仍容易出现偶尔的分析误差。促肾上腺皮质激素(ACTH)是易受测定干扰的激素之一。

目的

在本病例报告中,我们旨在呈现一例亚临床库欣综合征患者出现ACTH干扰的病例。

病例报告

我们报告一例亚临床库欣综合征患者,其ACTH水平意外升高,通过不同生化方法显示存在干扰。当临床和实验室结果不一致时,临床医生牢记干扰的可能性很重要。在解释结果时,临床医生与实验室工作人员之间的沟通很重要。本病例报告表明,对于ACTH水平意外升高的亚临床库欣综合征患者,应考虑ACTH干扰的情况。

相似文献

1
ADRENOCORTICOTROPIC HORMONE IMMUNOASSAY INTERFERENCE IN A PATIENT WITH SUBCLINICAL HYPERCORTISOLISM.
Acta Endocrinol (Buchar). 2020 Jul-Sep;16(3):379-382. doi: 10.4183/aeb.2020.379.
2
Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.
Endocrine. 2017 May;56(2):308-316. doi: 10.1007/s12020-017-1268-7. Epub 2017 Feb 28.
4
Corticotropin hormone assay interference: A case series.
Clin Biochem. 2019 Jan;63:143-147. doi: 10.1016/j.clinbiochem.2018.11.006. Epub 2018 Nov 10.
5
Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
Endocr J. 2014;61(10):941-8. doi: 10.1507/endocrj.ej14-0120. Epub 2014 Jun 29.
6
Elevated Adrenocorticotropic Hormone, Hypercortisolism, and Marked Hypernatremia.
Cureus. 2021 Nov 18;13(11):e19714. doi: 10.7759/cureus.19714. eCollection 2021 Nov.
7
9
Subclinical Cushing's syndrome in adrenal incidentaloma.
Clin Endocrinol (Oxf). 1998 Jan;48(1):89-97. doi: 10.1046/j.1365-2265.1998.00357.x.
10
[Subclinical hypercortisolism in incidentally detected adrenal adenoma].
Dtsch Med Wochenschr. 1996 Apr 19;121(16):503-7; discussion 508. doi: 10.1055/s-2008-1043033.

引用本文的文献

本文引用的文献

1
An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results.
Clin Chem. 2019 Nov;65(11):1397-1404. doi: 10.1373/clinchem.2019.306365. Epub 2019 Sep 30.
2
Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities.
J Endocr Soc. 2019 Apr 11;3(5):1097-1109. doi: 10.1210/js.2018-00382. eCollection 2019 May 1.
3
Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure-A Case Series.
J Endocr Soc. 2019 Feb 20;3(4):763-772. doi: 10.1210/js.2019-00027. eCollection 2019 Apr 1.
4
Corticotropin hormone assay interference: A case series.
Clin Biochem. 2019 Jan;63:143-147. doi: 10.1016/j.clinbiochem.2018.11.006. Epub 2018 Nov 10.
5
Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.
Endocrine. 2017 May;56(2):308-316. doi: 10.1007/s12020-017-1268-7. Epub 2017 Feb 28.
6
Subclinical Hypercortisolism: How to Deal with It?
Front Horm Res. 2016;46:28-38. doi: 10.1159/000443862. Epub 2016 May 17.
7
Calcitonin measurement and immunoassay interference: a case report and literature review.
Clin Chem Lab Med. 2016 Dec 1;54(12):1861-1870. doi: 10.1515/cclm-2015-1161.
8
Clinical significance of screening for subclinical Cushing's disease in patients with pituitary tumors.
Endocr J. 2016;63(1):47-52. doi: 10.1507/endocrj.EJ15-0446. Epub 2015 Nov 3.
9
A Case With Immunoassay Interferences in the Measurement of Multiple Hormones.
J Clin Endocrinol Metab. 2015 Jun;100(6):2147-53. doi: 10.1210/jc.2014-4023. Epub 2015 Apr 21.
10
Heterophilic antibody interference in immunometric assays.
Best Pract Res Clin Endocrinol Metab. 2013 Oct;27(5):647-61. doi: 10.1016/j.beem.2013.05.011. Epub 2013 Jun 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验